- Home
- TWIN vs TVGN Comparison
TWIN vs TVGN Comparison
Compare TWIN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWIN
- TVGN
- Stock Information
- Founded
- TWIN 1918
- TVGN 2020
- Country
- TWIN United States
- TVGN United States
- Employees
- TWIN N/A
- TVGN N/A
- Industry
- TWIN Industrial Machinery/Components
- TVGN Blank Checks
- Sector
- TWIN Industrials
- TVGN Finance
- Exchange
- TWIN Nasdaq
- TVGN Nasdaq
- Market Cap
- TWIN 152.3M
- TVGN 174.4M
- IPO Year
- TWIN N/A
- TVGN N/A
- Fundamental
- Price
- TWIN $11.47
- TVGN $1.30
- Analyst Decision
- TWIN
- TVGN
- Analyst Count
- TWIN 0
- TVGN 0
- Target Price
- TWIN N/A
- TVGN N/A
- AVG Volume (30 Days)
- TWIN 22.9K
- TVGN 1.6M
- Earning Date
- TWIN 02-05-2025
- TVGN 02-20-2025
- Dividend Yield
- TWIN 1.41%
- TVGN N/A
- EPS Growth
- TWIN N/A
- TVGN N/A
- EPS
- TWIN 0.68
- TVGN N/A
- Revenue
- TWIN $304,470,000.00
- TVGN N/A
- Revenue This Year
- TWIN N/A
- TVGN N/A
- Revenue Next Year
- TWIN N/A
- TVGN N/A
- P/E Ratio
- TWIN $16.60
- TVGN N/A
- Revenue Growth
- TWIN 6.98
- TVGN N/A
- 52 Week Low
- TWIN $10.22
- TVGN $0.26
- 52 Week High
- TWIN $18.00
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- TWIN 49.71
- TVGN 52.42
- Support Level
- TWIN $10.98
- TVGN $1.21
- Resistance Level
- TWIN $11.46
- TVGN $1.57
- Average True Range (ATR)
- TWIN 0.41
- TVGN 0.15
- MACD
- TWIN 0.02
- TVGN 0.01
- Stochastic Oscillator
- TWIN 67.57
- TVGN 48.54
About TWIN Twin Disc Incorporated
Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.